Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Innovation Council · Running

MIRACLE MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care

Coordinator
Wavetronica BV, Netherlands
Runs
1 May 2022 to 31 July 2025
Status
Running
EU funding
€2.5m
Total cost
€2.5m
Partners
4 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101058125

What the project is doing

In the project's own words, from its summary on CORDIS.

Imagine a future where the limitless possibilities of virtual biopsies in cancer diagnostics can be explored. A future in which cancer patients would have access to MRI enabled virtual biopsies in order to receive the best possible treatment decisions anywhere on the globe. MIRACLE is developing a first-of-kind add-on device for MRI scanners that will be used to acquire a virtual biopsy of the tumor providing not only structural information on tumor dimensions for (tissue conserving) surgery, but also unique metabolic information on the efficacy of specific systemic therapies.

Ultimately, this fully non-invasive, accurate and rapid predictive approach can guide patients to the best fitting treatment plan given their personal circumstances and tumor characteristics. WaveTronica (WT) together with the University Medical Centre Utrecht (UMCU), German Cancer Research Centre (DKFZ) and Medical University of Lublin (UMLUB) aim to build this future by bringing the first Metabolic MRI-as-a-Service solution to the market.

Past projects and research led to the development of a Proof-of-Concept MRI coil capable of detecting metabolic biomarkers non-invasively using the strongest clinically available MRI system, as demonstrated in FET- OPEN-01-2016-2017-801075 - the Non-Invasive-Chemistry-Imaging (NICI) and FET-OPEN-03-2018-2019-2020 - FET Innovation Launchpad - MIRACLE. The MRI coil is a plug-and-play add on for existing MRI machines resulting in an accessible and affordable virtual biopsy tool that can identify cancer biomarkers and tumor activity without shedding a drop of patient blood.

This project converts a complex research tool into an accessible diagnostic service (Metabolic MRI-as-a-Service). MIRACLE is supported by the Dutch reimbursement company VGZ, Tesla DC, and oncologists showing there is a strong market demand. Now the challenge lies in bringing the breast coil PoC hardware and software to the next level using breast cancer as a use case.

Topics

Who is involved

OrganisationCityCountryRole
Wavetronica BVUtrechtNetherlandsCoordinator
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Uniwersytet Medyczny W LublinieLublinPolandParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI